Qilu Pharm`s Generic Exemestane Receives Approval in US
Mayne Pharma’s Generic Exemestane Receives Approval In US
Amneal Pharms's Generic Exemestane Receives Approval in US
Zydus Pharms USA Inc's Generic Exemestane Receives Approval in US
Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin
Cipla’s Generic Exemestane Receives Approval In US
Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of Exemestane Tablets, 25 mg. The company recently received U.S. Food and Drug Administration (FDA) approval of its abbreviated new drug application (ANDA) for the product. Exemestane Tablets are equivalent (AB-rated) to the branded product, Aromasin®.*
Upsher-Smith’s Generic Exemestane Receives Approval In US
Mylan Pharm’s Generic Exemestane Receives Approval In US
Anvisa approves drugs for cancer and polio vaccine to 1.2 and 3